Speaker(s): 
Alison Walck, PharmD, Ambulatory Clinical Pharmacist, Geisinger Primary Care has nothing to disclose.

Moderator(s): 
Adriene Zook, PharmD, RPH, Geisinger Pharmacy Manager, Medication Therapy Disease Management, has nothing to disclose.

Learning Objectives: 
At the conclusion of this session, the participant should be able to: 

• Cite pre-operative diabetes medication recommendations 
• Summarize physiological changes post bariatric surgery leading to changes in type 2 diabetes treatment 
• Construct appropriate type 2 diabetes medication therapy status post bariatric surgery 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Stacy Coolbaugh, MBA, RDN, LDN; Angela Esherick, RDN, LDN, CDCES; Adriene Zook, PharmD, RPH, Dan Huston, DNP, RN, BC-ADM, and Angela Zammit have no identified disclosures. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 
This presentation/content is HIPPA compliant.